$29.05▲1.74 (6.37%)
After Hours:$29.09+0.04 (+0.14%)
Ionis Pharmaceuticals, Inc. (IONS)
R&D to Revenue
97.03%
Fiscal year · Period ending:

IONS R&D to Revenue
Latest reported97.03%period ending
Latest reported97.03%period ending
IONS FY R&D/Revenue (0.00% → 97.03%)
Latest values, visible window
High-resolution chart · PNG
What is r&d to revenue?
R&D spending as percentage of revenue.
IONS r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 97.0339% | |
| 127.8516% | |
| 114.2168% | |
| 141.8193% | |
| 79.3381% | |
| 73.3616% | |
| 41.5108% | |
| 69.1382% | |
| 72.8626% | |
| 92.3665% | |
| 113.6019% | |
| 112.8828% | |
| 124.9503% | |
| 155.2764% | |
| 158.8489% | |
| 133.8213% | |
| 110.7097% | |
| 99.2994% | |
| 158.7841% | |
| 542.2101% | |
| 205.4843% | |
| 277.9514% | |
| 233.9728% | |
| 154.7463% | |
| 157.1922% | |
| 153.0372% | |
| 195.8702% | |
| 158.6735% | |
| 170.948% | |
| 201.3216% | |
| 255.3846% | |
| 262.3762% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |
Explore More
IONS Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance